Impact of the Covid-19 Pandemic on Colorectal Cancer Surgery in Madrid

• Published in: Journal of Coloproctology Vol. 41; no. 3; pp. 257 - 264
• Main Authors: Labalde Martínez, Maria, García Borda, Francisco Javier, Narvaez Chavez, Cristina, Vivas Lopez, Alfredo, García Villar, Oscar, Gomez, Ramón, Ramos Martinez, Rafael, de La Cruz Vigo, Felipe, Ferrero Herrero, Eduardo
• Format: Journal Article
• Language: English
• Published: Thieme Revinter Publicações Ltda 01-09-2021
• Subjects: colorectal cancer surgery; covid-19 pandemic; oncological surgery; sars-cov-2 infection; surgical patients
• ISSN: 2237-9363; 2317-6423
• DOI: 10.1055/s-0041-1730017

Abstract
Introduction The Covid-19 pandemic has had an important impact on colorectal cancer surgery, for hospital resources had to be redistributed in favour of Covid-19 patients. The aim of the present study is to analyze our results in colorectal oncologic surgery during the Covid-19 pandemic in patients with and without perioperative SARS-CoV-2 infection.
Methods In total, 32 patients (19 male and 13 female patients), with a mean age of 64 years (range: 57.2 to 69.5 years) with colorectal cancer underwent surgery under the recommendations of surgical societies included in a protocol. Data collection included clinical characteristics (gender, age, body mass index, American Society of Anesthesiologists score, tumor location, preoperative staging, lymphopenia), data related to SARS-CoV-2 infection (postoperative symptoms, diagnostic tests), operative details (surgical procedure, approach, duration, stoma), pathological outcomes (tumor stage, number of lymph nodes harvested, distal and circumferential radial margins, quality of the total mesorectal excision), and surgical outcomes (morbidity, mortality, hospital stay, and the rates of reoperation and readmission).
Results A total of 3 (9.4%) patients who underwent colorectal surgery during the Covid-19 pandemic were infected by SARS-CoV-2 in the postoperative period. Chronic obstructive pulmonary disease was associated with Covid-19 (6.2% versus 33.3%; p = 0.042), and surgical morbidity was higher among Covid-19 patients (100% versus 37.9%; p = 0.039). There were not significant differences between COVID-19 patients and non-COVID-19 patients in relation to the rest of the analyzed outcomes.
Conclusion During the Covid-19 pandemic, colorectal cancer surgery should be performed according to the recommendations of surgical societies. However, Covid-19 patients could present a higher morbidity rate.